Slide 1: 9M 2023 Results Presentation
• 9M 2023 RESULTS PRESENTATION • November 9th, 2023
Slide 2: Executive Summary
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Executive Summary Key 9M 2023 trends and figures 9M 2023 Sales up +14.5% YoY driven by Healthcare and Safety divisions 9M 2023 Adjusted EBITDA at € 69.1m, +21.4
Slide 3: GVS – 9M 2023 Results At-a-Glance
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx GVS – 9M 2023 Results At-a-Glance Continuous sales growth, profitability recovery and NFP reduction SALES Adjusted EBITDA and % Adjusted NFP and Leverage €m €m
Slide 4: Focus on Sales – 9M 2023 vs. 9M 2022
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Focus on Sales – 9M 2023 vs. 9M 2022 Organic sales (excl. FX) +1.4% vs. 9M 2022 SALES – 9M 2022 TO 9M 2023 BRIDGE €m • 9M 2023 organic sales growing +1.4% vs. 9
Slide 5: Focus on Sales – 9M 2023 Performance by Division
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Focus on Sales – 9M 2023 Performance by Division Healthcare and Safety leading organic growth, despite de-stocking Healthcare & Life Sciences Health & Safety En
Slide 6: Focus on Profitability – EBITDA 9M 2023 vs. 9M 2022
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Focus on Profitability – EBITDA 9M 2023 vs. 9M 2022 +7.6% like-for-like growth driven by pricing EBITDA – 9M 2022 TO 9M 2023 BRIDGE €m 20.8% ADJUSTED EBITDA % 2
Slide 7: Focus on Debt – NFP Adjusted 9M 2023 vs. FY 2022
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Focus on Debt – NFP Adjusted 9M 2023 vs. FY 2022 Deleverage driven by operating cash generation NET FINANCIAL POSITION ADJUSTED – FY 2022 TO 9M 2023 BRIDGE €m 3
Slide 8: Appendix – Support Material
Appendix – Support Material
Slide 9: 9M 2023 Results – Financial Statements
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx 9M 2023 Results – Financial Statements 9M 2022 and 9M 2023 P&L – Statutory Adjusted View of which 9M 2022 of which 9M 2023 €m 9M 2022 % 9M 2023 % non-recurring
Slide 10: 9M 2023 Results – Financial Statements
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx 9M 2023 Results – Financial Statements Reclassified Balance Sheet - FY 2022 – 9M 2023 FY 2022 9M 2023 €m Net intangible fixed assets 494.8 484.3 Net usage right
Slide 11: 9M 2023 Results – Financial Statements
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx 9M 2023 Results – Financial Statements Cash Flow Statement – 9M 2022 – 9M 2023 €m 9M 2022 9M 2023 Pre-tax result 60.6 21.1 Amortisation, depreciation and writed
Slide 12: Disclaimer
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Disclaimer Pursuant to art. 154-bis, paragraph 2, of the Italian Unified Financial Act of February 24, 1998, the executive in charge of preparing the corporate